{"id":106962,"date":"2025-10-28T16:37:59","date_gmt":"2025-10-28T15:37:59","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-strengthens-its-leadership-in-innovative-therapies-against-idps-thanks-to-the-support-of-the-torres-quevedo-program\/"},"modified":"2025-10-28T16:37:59","modified_gmt":"2025-10-28T15:37:59","slug":"nuage-therapeutics-strengthens-its-leadership-in-innovative-therapies-against-idps-thanks-to-the-support-of-the-torres-quevedo-program","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/en\/nuage-therapeutics-strengthens-its-leadership-in-innovative-therapies-against-idps-thanks-to-the-support-of-the-torres-quevedo-program\/","title":{"rendered":"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program"},"content":{"rendered":"

Nuage Therapeutics<\/a>, a spinoff of the Institute for Research in Biomedicine (IRB Barcelona<\/a>) based at the Barcelona Science Park, has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994), consolidating its innovative role in the discovery of new drugs targeting therapeutic targets traditionally considered intractable, such as intrinsically disordered proteins (IDPs), which are associated with serious diseases like cancer and have so far remained beyond the reach of conventional treatments.<\/strong><\/p>\n

The completed projects have focused on the development of a new approach to drug discovery, enabling the targeting of intrinsically disordered proteins (IDPs) and giving rise to a new generation of transformative therapies. IDPs are a class of proteins that for a long time were considered inaccessible to drugs. This advance opens the door to revolutionary therapeutic solutions.<\/p>\n

Currently, Nuage Therapeutics is applying this innovative approach to address transcription factors that drive the growth of certain types of cancer, offering a revolutionary strategy for the treatment of specific tumors.<\/p>\n

The execution of these projects has had a positive impact on the company\u2019s growth and trajectory, achieving several notable milestones. Among them, the attraction of international investment stands out: Sofinnova Partners, one of Europe\u2019s most prestigious venture capital firms in the biotechnology sector, has joined Nuage, marking a significant step in the company\u2019s growth and expansion.<\/p>\n

In addition, Nuage has strengthened its presence in competitive R&D programs, both nationally and at the European level. The company has been awarded highly selective grants, including the Public-Private Collaboration Projects of the AEI and Eurostars 2025. These collaborations not only reinforce public-private partnerships but also promote the internationalization of Nuage\u2019s research and development activities.<\/p>\n

Finally, the company has achieved significant advances in its research pipeline. Nuage\u2019s proprietary technology has demonstrated efficacy against new intrinsically disordered proteins (IDPs), such as ASCL1, KLF5, and SOX2, highlighting the platform\u2019s potential to address a broader range of therapeutic needs and consolidating its position as a leader in innovative therapies.<\/p>\n

The Torres Quevedo Program is awarded by the State Research Agency (AEI) within the framework of the 2021-2023 State Plan for Scientific, Technical, and Innovation Research.<\/p>\n

\u00bb Link to the news:<\/strong> Nuage Therapeutics website [+]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Nuage Therapeutics, a spinoff of the Institute for Research in Biomedicine (IRB Barcelona) based at the Barcelona Science Park, has successfully completed two projects funded through the Torres Quevedo Program…<\/p>\n","protected":false},"author":14,"featured_media":104432,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[90],"tags":[294],"class_list":["post-106962","post","type-post","status-publish","format-standard","has-post-thumbnail","category-entities","tag-nuage-therapeutics-en"],"acf":[],"yoast_head":"\nNuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"description\" content=\"The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T15:37:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/05\/Adobe-Express-file-10.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program\",\"datePublished\":\"2025-10-28T15:37:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Adobe-Express-file-10.png\",\"keywords\":[\"Nuage Therapeutics\"],\"articleSection\":[\"ENTITIES\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/\",\"name\":\"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Adobe-Express-file-10.png\",\"datePublished\":\"2025-10-28T15:37:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"description\":\"The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Adobe-Express-file-10.png\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Adobe-Express-file-10.png\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Cient\u00edfic de Barcelona","description":"The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/","og_locale":"en_US","og_type":"article","og_title":"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Cient\u00edfic de Barcelona","og_description":"The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).","og_url":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2025-10-28T15:37:59+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/05\/Adobe-Express-file-10.png","type":"image\/png"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paula Ca\u00f1al","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program","datePublished":"2025-10-28T15:37:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/"},"wordCount":386,"image":{"@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/05\/Adobe-Express-file-10.png","keywords":["Nuage Therapeutics"],"articleSection":["ENTITIES"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/","url":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/","name":"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/05\/Adobe-Express-file-10.png","datePublished":"2025-10-28T15:37:59+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"description":"The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).","breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/05\/Adobe-Express-file-10.png","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/05\/Adobe-Express-file-10.png","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/nuage-therapeutics-impulsa-el-seu-lideratge-en-terapies-innovadores-contra-idps-gracies-al-suport-del-programa-torres-quevedo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/en\/"},{"@type":"ListItem","position":2,"name":"Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/en\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/106962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/comments?post=106962"}],"version-history":[{"count":0,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/106962\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media\/104432"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media?parent=106962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/categories?post=106962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/tags?post=106962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}